<DOC>
	<DOCNO>NCT02537002</DOCNO>
	<brief_summary>The purpose study follow : - To determine safety tolerability single ascend intravenous ( IV ) dose PF-05230907 healthy Japanese subject . - To characterize PK profile single ascend IV dos PF-05230907 healthy Japanese subject . - To characterize PD profile single ascend IV dos PF-05230907 healthy Japanese subject . - To evaluate immunogenicity PF-05230907 healthy Japanese subject</brief_summary>
	<brief_title>Single Dose Study PF-05230907 Healthy Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male female Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) &lt; 120 kg ( 265 lb ) . Japanese subject four biologic Japanese grandparent born Japan . Pregnant nursing female . Females childbearing potential unwilling unable use acceptable method contraception . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>PF-05230907</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Immunogenicity</keyword>
</DOC>